Form 8-K · Current report
Gen Digital 8-K, filed Oct 28, 2026
- Filed
- CIK
- 0000849399
- Accession no.
- 0000849399-26-000081
Summary
Gen Digital reported second-quarter fiscal 2027 revenue of $1.369 billion, up 12% year over year, and raised its full-year fiscal 2027 revenue and EPS guidance. CEO Vincent Pilette cited a sixth consecutive quarter of double-digit bookings growth and a record customer count, and CFO Natalie Derse attributed the results to strong customer demand and disciplined investment.
Key points
- Q2 GAAP diluted EPS was $0.48, up 122%; non-GAAP diluted EPS was $0.74, up 19%.
- Q2 bookings were $1.347 billion, up 10%, and non-GAAP operating income was $686 million, up 10%.
- Full-year fiscal 2027 revenue guidance was raised to $5.465–$5.515 billion from $5.375–$5.475 billion, and EPS guidance to $2.93–$2.98 from $2.87–$2.97.
- The board approved a quarterly cash dividend of $0.125 per share, payable December 9, 2026 to shareholders of record as of November 16, 2026.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02. Results of Operations and Financial Conditions On October 28, 2026, Gen Digital Inc. (the Company) issued a press release announcing financial results for the second quarter ended October 2, 2026. The Company also posted supplemental financial information to its website. A copy of the press release is furnished as Exhibit 99.01 to this Current Report on Form 8-K and is incorporated herein by reference. The information in this Item 2.02, including Exhibit 99.01 hereto, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.